Importantly, these CE7R+ TCM cells were capable of secreting high levels of IFN-γ and TNF-α, and exhibited robust and specific in vitro lytic activity against L1-CAM/CE7+ ovarian tumor cells—both established lines and primary tumor cells derived from the malignant ascites of ovarian cancer patients. The gene discussed is TNF; the disease is ovarian carcinoma.